Abstract:Background: Benign prostatic hyperplasia (BPH) is a common chronic progressive disease resulting in urinary obstruction in aging men. It comes to more and more patients with massive BPH with the aging of society and extension of life expectancy. Objective: The aim of the study was to compare the clinical efficacy, safety, and complications between transurethral bipolar plasmakinetic enucleation of the prostate (PKEP) and transurethral resection of the prostate (TURP) in the treatment of massive BPH. Design and setting: Patients with BPH were divided into the PKEP group and the TURP group randomly. Intraoperative blood loss (BL), operation time (OT), resected tissue weight (RTW), gland resection ratio (GRR), postoperative indwelling ureter time (IUT), bladder fistula time (BFT) and hospital stay time (HST), preoperative and postoperative serum sodium concentration (SSC), hemoglobin concentration (HGB), prostate weight (PW), postvoid residual (PVR), maximum urinary flow rate (Qmax), international prostate symptom score (IPSS), quality of life (QOL), International Index of Erectile Function (IIEF), and other complications were analyzed and compared respectively. Results: There was no statistical difference in preoperative IPSS, preoperative QOL score, preoperative PVR, preoperative Qmax, postoperative QOL score, postoperative PVR, postoperative Qmax, IPSS difference value (DV), Qmax DV, and PVR DV between the PKEP group and the TURP group (p > 0.05). OT, BL, IUT, BFT, HST, and postoperative IPSS in the PKEP group were significantly lower than that in the TURP group (p < 0.01). RTW and GRR in the PKEP group were significantly higher than that in the TURP group (p < 0.01). QOL DV in the PKEP group was higher than that in the TURP group (p < 0.05). There was statistical difference in SSC DV between the PKEP group and the TURP group (p < 0.05). There was significant statistical difference in postoperative PW, postoperative HGB, PW DV, and HGB DV between the PKEP group and the TURP group (p < 0.01). There was significant statistical difference in IPSS, QOL, PVR, and Qmax between postoperative value and preoperative value in both groups (p < 0.01). The incidence of transurethral resection syndrome, obturator nerve reflex, transient urinary incontinence, and retrograde ejaculation between the PKEP group and the TURP group has no statistical difference (p > 0.05). Capsule perforation, blood transfusion, secondary hemorrhage, bladder neck contracture, and urethral stricture in the PKEP group were lower than that in the TURP group (p < 0.05). Bladder spasm in the PKEP group was significantly lower than that in the TURP group (p < 0.01). There was no statistical difference in preoperative and postoperative IIEF-5, effective erectile frequency, telotism average tension, sustainable telotism average time, and sexual dissatisfaction between the PKEP group and the TURP group (p > 0.05). Conclusions: PKEP and TURP have similar clinical efficacy in the treatment of massive BPH. PKEP has advantages in shorter OT, less BL, more GRR, and fewer complications, but the long-term therapeutic effect of PKEP needs further follow-up.

Application of Suprapubic Needle Aspiration of Bladder to Transurethral Bipolar Plasmakinetic Resection of the Prostate

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

A comparative study of two means of simultaneous treatment for benign prostate hyperplasia and bladder stone

Radical Retropubic Prostatectomy (with a Report of 53 Cases)

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

An evaluation of transurethral plasma kinetic resection versus transurethral resection of the prostate for the treatment of symptomatic BPH

Comparison of efficacy and safety between transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics

Comparative Study of the Effectiveness and Safety of Transurethral Bipolar Plasmakinetic Enucleation of the Prostate and Transurethral Bipolar Plasmakinetic Resection of the Prostate for Massive Benign Prostate Hyperplasia (>80 ml)

[Transurethral Plasmakinetic Enucleation of Prostate and Suprapubic Small Cut in the Treatment of High Risk and Senior Patient with Benign Prostatic Hyperplasia and Bladder Stones].

Efficacy and Safety of Bipolar Plasma Vaporization of the Prostate with "Button-Type" Electrode Compared with Transurethral Resection of Prostate for Benign Prostatic Hyperplasia.

[Transurethral bipolar plasmakinetic enucleation and resection versus transurethral bipolar plasmakinetic resection of the prostate for BPH: a randomized controlled trial on the incidence of postoperative urinary incontinence]

Two-year Outcome of High-risk Benign Prostate Hyperplasia Patients Treated with Transurethral Prostate Resection by Plasmakinetic or Conventional Procedure

Impact of Plasmakinetic Resection of Prostate on Sexual Function in Patients with Benign Prostatic Hyperplasia

Transurethral plasma kinetic resection of superficial bladder tumor

Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia

Comparison of Fluid Absorption Between Transurethral Enucleation and Transurethral Resection for Benign Prostate Hyperplasia

Outcomes and Prognostic Factors of Transurethral Bipolar Plasmakinetic Resection of the Bladder Tumor in Renal Transplant Recipients

[Application value of ultrasound technology in transurethral enucleation and resection of the prostate]

Feasibility and safety of bipolar-plasmakinetic transurethral enucleation and resection of the prostate in day surgery mode

Clinical effect of bipolar plasmakinetic transurethral enucleation in the treatment of benign prostatic hyperplasia

A comparative study on the efficacy and safety of modified plasma kinetic resection of the prostate and transurethral resection of the prostate in the treatment of benign prostatic hyperplasia